Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
938 000
KRW
-1.16%
Market Closed
Market Cap:
66.8T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Samsung Biologics Co Ltd
938000
-11000 (-1.16%)
| 52 Week Range |
722 000
999 999.9999
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Samsung Biologics Co Ltd
Cash Flow Statement
Cash Flow Statement
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Currency: KRW
| Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||||||||
| Net Income |
1 913 289
|
1 869 184
|
(176 823)
|
(184 194)
|
(156 258)
|
(143 852)
|
(96 972)
|
(110 558)
|
(107 990)
|
(103 273)
|
224 109
|
232 318
|
238 438
|
309 563
|
202 904
|
278 007
|
343 437
|
355 375
|
240 975
|
265 298
|
334 801
|
410 494
|
393 589
|
479 556
|
510 074
|
507 465
|
798 056
|
792 869
|
825 714
|
936 917
|
857 691
|
895 298
|
1 028 404
|
1 052 506
|
|
| Depreciation & Amortization |
52 630
|
68 195
|
60 149
|
63 758
|
64 790
|
66 453
|
69 926
|
74 038
|
78 070
|
81 928
|
91 450
|
103 094
|
115 289
|
127 864
|
132 543
|
134 325
|
136 635
|
139 520
|
143 175
|
148 356
|
152 715
|
156 969
|
161 789
|
164 906
|
214 137
|
257 989
|
308 264
|
366 660
|
386 413
|
440 285
|
489 782
|
532 521
|
571 932
|
590 229
|
|
| Other Non-Cash Items |
(2 062 552)
|
(2 025 592)
|
151 342
|
175 975
|
146 810
|
163 097
|
161 539
|
183 360
|
214 290
|
203 644
|
(142 995)
|
(171 502)
|
(216 268)
|
(274 263)
|
(85 583)
|
(79 166)
|
(46 649)
|
(38 339)
|
66 158
|
50 824
|
70 880
|
126 871
|
187 832
|
212 060
|
221 070
|
408 284
|
289 411
|
322 723
|
309 899
|
164 264
|
312 968
|
321 642
|
377 374
|
383 411
|
|
| Cash Taxes Paid |
(274)
|
(274)
|
(63)
|
0
|
(150)
|
(150)
|
(150)
|
31
|
456
|
748
|
1 131
|
0
|
40 260
|
42 145
|
42 105
|
47 360
|
15 466
|
26 041
|
38 429
|
42 241
|
49 217
|
54 860
|
42 369
|
81 416
|
135 197
|
178 692
|
188 473
|
246 675
|
294 899
|
274 326
|
319 321
|
216 674
|
288 424
|
313 194
|
|
| Cash Interest Paid |
14 794
|
21 200
|
24 362
|
24 466
|
22 297
|
19 463
|
17 036
|
15 465
|
16 574
|
20 053
|
23 359
|
26 366
|
28 118
|
27 602
|
26 345
|
23 756
|
20 832
|
17 902
|
15 630
|
15 287
|
15 485
|
15 008
|
18 594
|
21 294
|
20 274
|
27 573
|
33 940
|
41 068
|
52 809
|
59 365
|
63 486
|
63 814
|
55 379
|
42 620
|
|
| Change in Working Capital |
(168 940)
|
(196 944)
|
(97 330)
|
(110 986)
|
(50 488)
|
(54 343)
|
15 323
|
(21 429)
|
(75 826)
|
(125 915)
|
(205 582)
|
(157 360)
|
(212 335)
|
(224 694)
|
(239 711)
|
(231 785)
|
(150 825)
|
(7 778)
|
(248 218)
|
(456 064)
|
(489 438)
|
(496 838)
|
(288 614)
|
(116 478)
|
(370 769)
|
(415 375)
|
(442 684)
|
(425 428)
|
(224 239)
|
(398 943)
|
5 787
|
(110 120)
|
(324 137)
|
76 410
|
|
| Cash from Operating Activities |
(265 573)
N/A
|
(285 158)
-7%
|
(62 661)
+78%
|
(55 446)
+12%
|
4 855
N/A
|
31 356
+546%
|
149 816
+378%
|
125 412
-16%
|
108 544
-13%
|
56 383
-48%
|
(33 017)
N/A
|
6 551
N/A
|
(74 877)
N/A
|
(61 528)
+18%
|
10 154
N/A
|
101 382
+898%
|
282 600
+179%
|
448 780
+59%
|
202 090
-55%
|
8 415
-96%
|
68 957
+719%
|
197 495
+186%
|
454 596
+130%
|
740 043
+63%
|
574 512
-22%
|
758 364
+32%
|
953 048
+26%
|
1 056 823
+11%
|
1 297 787
+23%
|
1 142 523
-12%
|
1 666 229
+46%
|
1 639 341
-2%
|
1 653 573
+1%
|
2 102 556
+27%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||
| Capital Expenditures |
(161 117)
|
(201 981)
|
(168 171)
|
(219 291)
|
(351 275)
|
(442 387)
|
(504 802)
|
(536 991)
|
(453 587)
|
(368 915)
|
(284 459)
|
(242 637)
|
(195 180)
|
(177 658)
|
(181 196)
|
(119 764)
|
(118 098)
|
(120 697)
|
(148 566)
|
(212 740)
|
(317 901)
|
(384 313)
|
(421 152)
|
(641 798)
|
(693 806)
|
(877 323)
|
(1 009 226)
|
(1 184 660)
|
(1 174 496)
|
(1 051 577)
|
(1 105 325)
|
(740 512)
|
(692 861)
|
(1 103 979)
|
|
| Other Items |
(53 693)
|
(53 693)
|
(1 204 653)
|
(914 653)
|
(417 481)
|
(417 495)
|
769 987
|
469 275
|
(400 714)
|
(370 700)
|
(346 931)
|
(237 458)
|
274 585
|
424 607
|
520 838
|
282 077
|
140 054
|
(170 015)
|
(270 120)
|
99 880
|
269 886
|
(302 442)
|
(512 337)
|
(319 108)
|
(3 603 376)
|
(2 707 516)
|
(2 097 252)
|
(1 652 395)
|
516 438
|
110 022
|
(460 981)
|
(631 339)
|
138 697
|
485 012
|
|
| Cash from Investing Activities |
(214 809)
N/A
|
(255 673)
-19%
|
(1 372 824)
-437%
|
(1 133 944)
+17%
|
(768 756)
+32%
|
(859 882)
-12%
|
265 185
N/A
|
(67 716)
N/A
|
(854 301)
-1 162%
|
(739 616)
+13%
|
(631 390)
+15%
|
(480 095)
+24%
|
79 405
N/A
|
246 950
+211%
|
339 642
+38%
|
162 313
-52%
|
21 955
-86%
|
(290 712)
N/A
|
(418 686)
-44%
|
(112 860)
+73%
|
(48 015)
+57%
|
(686 755)
-1 330%
|
(933 489)
-36%
|
(960 907)
-3%
|
(4 297 182)
-347%
|
(3 584 838)
+17%
|
(3 106 477)
+13%
|
(2 837 056)
+9%
|
(658 059)
+77%
|
(941 555)
-43%
|
(1 566 305)
-66%
|
(1 371 851)
+12%
|
(554 164)
+60%
|
(618 967)
-12%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
1 484 261
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 188 321
|
3 200 751
|
3 200 751
|
3 200 871
|
12 550
|
200
|
200
|
80
|
80
|
0
|
|
| Net Issuance of Debt |
354 931
|
404 855
|
147 030
|
(247 414)
|
(358 176)
|
(378 100)
|
(287 176)
|
112 874
|
422 615
|
386 365
|
323 941
|
184 938
|
(81 820)
|
(184 016)
|
(239 806)
|
(269 976)
|
(243 778)
|
(118 862)
|
122 560
|
125 933
|
(7 005)
|
567 707
|
496 622
|
539 695
|
662 149
|
(143 257)
|
(188 241)
|
(272 148)
|
(327 452)
|
(292 673)
|
(635 250)
|
(751 616)
|
(699 727)
|
(1 233 652)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12 430)
|
(12 430)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
488 615
N/A
|
538 539
+10%
|
1 631 292
+203%
|
1 236 848
-24%
|
1 126 086
-9%
|
1 106 162
-2%
|
(287 176)
N/A
|
112 874
N/A
|
422 615
+274%
|
386 365
-9%
|
323 941
-16%
|
184 938
-43%
|
(81 820)
N/A
|
(184 016)
-125%
|
(239 806)
-30%
|
(269 976)
-13%
|
(243 778)
+10%
|
(118 862)
+51%
|
122 560
N/A
|
125 933
+3%
|
(7 005)
N/A
|
567 707
N/A
|
496 622
-13%
|
539 695
+9%
|
3 850 469
+613%
|
3 045 064
-21%
|
3 000 080
-1%
|
2 916 293
-3%
|
(327 332)
N/A
|
(292 473)
+11%
|
(635 050)
-117%
|
(751 536)
-18%
|
(699 647)
+7%
|
(1 233 652)
-76%
|
|
| Change in Cash | |||||||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
275
|
(310)
|
22
|
0
|
0
|
0
|
(76)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2 511)
|
(2 199)
|
(2 418)
|
(2 684)
|
(2 215)
|
(1 811)
|
(1 445)
|
2 084
|
831
|
2 594
|
3 751
|
19 291
|
(3 242)
|
4 263
|
9 416
|
(4 743)
|
12 245
|
21 934
|
38 930
|
11 104
|
|
| Net Change in Cash |
8 508
N/A
|
(2 602)
N/A
|
195 829
N/A
|
47 458
-76%
|
362 185
+663%
|
277 636
-23%
|
127 749
-54%
|
170 570
+34%
|
(323 142)
N/A
|
(296 868)
+8%
|
(340 466)
-15%
|
(288 606)
+15%
|
(77 292)
+73%
|
1 406
N/A
|
107 479
+7 544%
|
(8 480)
N/A
|
58 359
N/A
|
36 522
-37%
|
(96 251)
N/A
|
19 677
N/A
|
12 492
-37%
|
80 530
+545%
|
18 560
-77%
|
321 426
+1 632%
|
131 551
-59%
|
237 880
+81%
|
843 409
+255%
|
1 140 323
+35%
|
321 813
-72%
|
(96 248)
N/A
|
(522 882)
-443%
|
(462 112)
+12%
|
438 692
N/A
|
261 041
-40%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||||||||
| Free Cash Flow |
(426 690)
N/A
|
(487 139)
-14%
|
(230 832)
+53%
|
(274 737)
-19%
|
(346 420)
-26%
|
(411 031)
-19%
|
(354 986)
+14%
|
(411 579)
-16%
|
(345 043)
+16%
|
(312 532)
+9%
|
(317 476)
-2%
|
(236 086)
+26%
|
(270 057)
-14%
|
(239 186)
+11%
|
(171 042)
+28%
|
(18 382)
+89%
|
164 502
N/A
|
328 083
+99%
|
53 524
-84%
|
(204 325)
N/A
|
(248 944)
-22%
|
(186 818)
+25%
|
33 444
N/A
|
98 245
+194%
|
(119 293)
N/A
|
(118 959)
+0%
|
(56 178)
+53%
|
(127 837)
-128%
|
123 290
N/A
|
90 946
-26%
|
560 904
+517%
|
898 829
+60%
|
960 712
+7%
|
998 577
+4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
